David Castro‐Díaz

6.7k total citations · 2 hit papers
144 papers, 3.7k citations indexed

About

David Castro‐Díaz is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, David Castro‐Díaz has authored 144 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Urology, 95 papers in Rheumatology and 41 papers in Epidemiology. Recurrent topics in David Castro‐Díaz's work include Pelvic floor disorders treatments (93 papers), Urinary Bladder and Prostate Research (88 papers) and Urinary Tract Infections Management (39 papers). David Castro‐Díaz is often cited by papers focused on Pelvic floor disorders treatments (93 papers), Urinary Bladder and Prostate Research (88 papers) and Urinary Tract Infections Management (39 papers). David Castro‐Díaz collaborates with scholars based in Spain, France and United Kingdom. David Castro‐Díaz's co-authors include Bertil Blok, Giulio Del Popolo, Jürgen Pannek, Jean‐Jacques Wyndaele, M. Stöhrer, Thomas M. Kessler, Jan Groen, G. Karsenty, E. Chartier-Kästler and Lisette ’t Hoen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Journal of Virology.

In The Last Decade

David Castro‐Díaz

133 papers receiving 3.6k citations

Hit Papers

EAU Guidelines on Neurogenic Lower Urinary Tract Dysfunction 2009 2026 2014 2020 2009 2015 100 200 300

Peers

David Castro‐Díaz
L. Cardozo United Kingdom
Paul Abrams United Kingdom
Tamara Bavendam United States
L. Keith Lloyd United States
Subbarao V. Yalla United States
Vik Khullar United Kingdom
Anne M. Suskind United States
Oliver Wiseman United Kingdom
David Castro‐Díaz
Citations per year, relative to David Castro‐Díaz David Castro‐Díaz (= 1×) peers Sender Herschorn

Countries citing papers authored by David Castro‐Díaz

Since Specialization
Citations

This map shows the geographic impact of David Castro‐Díaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Castro‐Díaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Castro‐Díaz more than expected).

Fields of papers citing papers by David Castro‐Díaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Castro‐Díaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Castro‐Díaz. The network helps show where David Castro‐Díaz may publish in the future.

Co-authorship network of co-authors of David Castro‐Díaz

This figure shows the co-authorship network connecting the top 25 collaborators of David Castro‐Díaz. A scholar is included among the top collaborators of David Castro‐Díaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Castro‐Díaz. David Castro‐Díaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borau, A., et al.. (2024). Consensus update on the therapeutic approach to patients with neurogenic detrusor overactivity. Actas Urológicas Españolas (English Edition). 48(9). 674–682.
2.
Caamaño, José Carlos, et al.. (2024). Convalescent Plasma Therapy in Severe COVID-19: A Pilot Study at the Beginning of the Pandemic Outbreak in Southern Chile. Revista médica de Chile. 152(3). 351–359. 1 indexed citations
3.
Castro‐Díaz, David, Nuno António, Ana Marreiros, & Hipólito Nzwalo. (2024). Understanding risk factors of post-stroke mortality. SHILAP Revista de lepidopterología. 5(1). 100181–100181.
4.
Padilla‐Fernández, Bárbara, et al.. (2022). Artificial Urinary Sphincter in a High-Risk Urethra: Transcorporal Gullwing Modification Description of the Technique. SHILAP Revista de lepidopterología. 48(6). 460–464. 3 indexed citations
5.
Sartori, Andrea M., Bárbara Padilla‐Fernández, Lisette ’t Hoen, et al.. (2021). Definitions of Urinary Tract Infection Used in Interventional Studies Involving Neurourological Patients—A Systematic Review. European Urology Focus. 8(5). 1386–1398. 15 indexed citations
6.
Alcaraz, Antonio, A. Rodrı́guez-Antolı́n, Joaquı́n Carballido, et al.. (2021). Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients. Scientific Reports. 11(1). 19401–19401. 10 indexed citations
7.
Chapple, Christopher R., Emma Mironska, Adrian Wagg, et al.. (2019). Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex. European Urology Focus. 6(3). 522–530. 21 indexed citations
8.
Chapple, Christopher R., David Castro‐Díaz, Yao‐Chi Chuang, et al.. (2016). Cross-sectional, internet-based survey to estimate prevalence of LUTS in China, Taiwan and South Korea (LUTS Asia). Neurourology and Urodynamics.
9.
López‐Fando, Luis, M. Esteban, A. Franco, et al.. (2015). ¿Cómo debemos abordar el diagnóstico de la vejiga hiperactiva en mujeres?. Actas Urológicas Españolas. 40(1). 29–36. 6 indexed citations
10.
Castro‐Díaz, David, Christopher R. Chapple, Zalmaï Hakimi, et al.. (2015). The effect of mirabegron on patient-related outcomes in patients with overactive bladder: the results of post hoc correlation and responder analyses using pooled data from three randomized Phase III trials. Quality of Life Research. 24(7). 1719–1727. 17 indexed citations
11.
Castro‐Díaz, David, Christopher R. Chapple, Zalmaï Hakimi, et al.. (2013). Post hoc responder analyses of subjective and objective outcomes using pooled data from 3 randomised Phase III trials of mirabegron in patients with overactive bladder. Neurourology and Urodynamics. 3 indexed citations
12.
Espuña‐Pons, Montserrat, David Castro‐Díaz, Helena Díaz-Cuervo, & Maite Pérez. (2013). Impact of overactive bladder treatment on the quality of life of patients over 60 with associated pathologies.. PubMed. 66(3). 287–94. 3 indexed citations
13.
14.
Herschorn, Sender, John Heesakkers, David Castro‐Díaz, et al.. (2008). Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms. Current Medical Research and Opinion. 24(12). 3513–3521. 27 indexed citations
15.
Cardozo, Linda, David Castro‐Díaz, Marc Gittelman, Arwin Ridder, & Moses Huang. (2006). Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin. International Urogynecology Journal. 17(5). 512–519. 32 indexed citations
16.
Artibani, Walter, Linda Cardozo, David Castro‐Díaz, et al.. (2006). Design and Validation of a New Screening Instrument for Lower Urinary Tract Dysfunction: The Bladder Control Self-Assessment Questionnaire (B-SAQ). European Urology. 52(1). 230–238. 38 indexed citations
17.
Castro‐Díaz, David, et al.. (2005). Pharmacotherapy for stress urinary incontinence. Current Opinion in Urology. 15(4). 227–230. 15 indexed citations
18.
Brainsky, Andrés, et al.. (2004). Controversias en el manejo del plastrón y el absceso apendicular: reporte de un caso. SHILAP Revista de lepidopterología. 2 indexed citations
19.
Abrams, Paul, G. Amarenco, August Bakke, et al.. (2003). Tamsulosin: Efficacy and Safety in Patients With Neurogenic Lower Urinary Tract Dysfunction Due to Suprasacral Spinal Cord Injury. The Journal of Urology. 170(4 Part 1). 1242–1251. 76 indexed citations
20.
Peraza, Simón, et al.. (1996). Cancer avanzado que simula cancer gastrico precoz . Presentacion de tres casos. Journal of Virology. 50(1). 42–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026